Original Publication Date: 1 November, 2016
Publication / Source: International Journal of Endocrine Oncology
Authors: Philippa K Wadsworth, Robert P Jones & Graeme J Poston
Gastroenteropancreatic neuroendocrine tumors often present at an advanced stage and carry a variable prognosis, with many patients living long periods even with metastatic disease. Resection of the primary tumor when liver metastases are unresectable is a contentious subject with no consensus between existing guidelines.